Website News and Research

RSS

Results from a preclinical study of Variation's influenza vaccine to be presented at ICAAC meeting

Variation Biotechnologies, Inc. (VBI), an emerging leader in the discovery and development of novel vaccines to fight infectious diseases, today announced that it plans to present positive results from a preclinical study of the company’s proprietary influenza vaccine at the 49th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), being held at the Moscone Convention Center in San Francisco, California.

11 Sep 2009

PPJ Enterprise focuses on business development of the medical billing firm PBS

PPJ Enterprise (PPJ) (PINKSHEETS: PPJE), a leader in proprietary automated healthcare multi-specialty provider reimbursement cycle technology and EHR development/information management digital system software for health care providers. PPJ Enterprises has focused all of its resources currently on the strategic business development of the medical billing firm PBS.

11 Sep 2009

HCD Research to conduct a national study during President Barack Obama's speech on health care reform

HCD Research announced today that it will conduct a national study during President Barack Obama's speech on health care reform tonight to obtain Americans' perceptions of the president and his plan for health care reform.

11 Sep 2009

Tetraphase to present its study on novel classes of antibiotics to treat drug-resistant infections

Tetraphase Pharmaceuticals Inc., a biopharmaceutical company capitalizing on breakthrough synthetic chemistry technology announced today that it will present three (3) posters and deliver a slide presentation on the synthesis and antibacterial activity of analogs from several novel classes of antibiotics to treat drug-resistant infections at the 49th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in San Francisco, CA.

11 Sep 2009

HHS, Ad Council and Warner Bros unite to address childhood obesity

The U.S. Department of Health and Human Services (HHS) and the Ad Council today launched a new series of public service advertisements (PSAs) designed to address childhood overweight and obesity.

11 Sep 2009

NHSA and Together Rx Access collaborate to improve prescription access

The National Head Start Association (NHSA) and Together Rx Access announced today a collaboration to launch the Together Rx Access(R) FOR HEAD START Card to help eligible uninsured individuals and families associated with Head Start access immediate and meaningful savings on prescription medicines and products right at their neighborhood pharmacies.

10 Sep 2009

Applications for the Pancreatic Cancer Action Network and AACR 2010 Research Grants Program invited

The Pancreatic Cancer Action Network, in partnership with the American Association for Cancer Research (AACR), is now accepting applications for the 2010 Research Grants Program. This year's grants program will be administered through the AACR's rigorous peer-review system to ensure the highest quality science is supported. The grant terms will begin on July 1, 2010.

10 Sep 2009

Season's Practice launches women health and wellness solutions in Northeast Ohio

Season's Practice has opened its doors to women in Northeast Ohio who are seeking alternative health and wellness solutions to improve their overall health and well-being.

10 Sep 2009

Inspire Pharmaceuticals to increase production of azithromycin ophthalmic solution

Inspire Pharmaceuticals, Inc. announced today that it has been communicating with the U.S. Food and Drug Administration (FDA) and is increasing its production of AzaSite® (azithromycin ophthalmic solution) 1% in response to the manufacturing supply shortage of erythromycin ophthalmic ointment (0.5%).

10 Sep 2009

Labopharm to present its novel trazodone formulation data

Labopharm Inc. today announced that three separate posters will be presented at three upcoming internationally prestigious medical meetings showcasing data on its novel trazodone formulation.

10 Sep 2009

Lead exposure may result in cardiovascular mortality

Growing evidence shows that exposure to lead in the environment is associated with cardiovascular disease, including increased risk of hypertension. However, those studies have looked at lead concentrations in blood, not bone lead, a better indicator of cumulative lead exposure over time.

10 Sep 2009

New website launched on food safety

Health and Human Services (HHS) Secretary Kathleen Sebelius and Agriculture (USDA) Secretary Tom Vilsack, the co-chairs of the Obama Administration’s Food Safety Working Group, unveiled a new consumer Web site today at www.foodsafety.gov. The site is designed to help consumers and families get all the latest information on food safety and food recalls in one convenient place.

10 Sep 2009

Three genes linked to Lou Gehrig's disease

Michigan Technological University researchers have linked three genes to the most common type of amyotrophic lateral sclerosis (ALS), generally known as Lou Gehrig's disease.

10 Sep 2009

Caldolor launched ahead of schedule in U.S. by Cumberland Pharmaceuticals

Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) announced today that it has successfully implemented the U.S. launch of Caldolor((R)), an intravenous formulation of ibuprofen, designed primarily for use in the hospital setting.

9 Sep 2009

A voluntary recall program announced by CONMED Linvatec

CONMED Corporation's (NASDAQ: CNMD) CONMED Linvatec unit announced today a voluntary recall for certain model numbers of the PRO5 & PRO6 series battery handpieces manufactured prior to May 31, 2008, and certain lots of the MC5057 Universal Cable manufactured prior to December 1, 2006 used with certain of CONMED Linvatec's electric powered handpieces.

9 Sep 2009

Protox Therapeutics to present TRIUMPH clinical study update

Protox Therapeutics Inc., a leader in the development of receptor targeted fusion proteins, today announced that Dr. Fahar Merchant, President & CEO of Protox Therapeutics, will present at the 11th Annual Rodman & Renshaw Healthcare Conference.

9 Sep 2009

Repros Therapeutics to sell 1.5 million shares to a single institutional investor

Repros Therapeutics (Nasdaq:RPRX) today announced that Repros has entered into a definitive agreement with a single institutional investor to sell 1.5 million shares of its common stock at $0.65 per share for gross proceeds of approximately $1.0 million.

9 Sep 2009

New web-based tool guide practices to become patient-centered medical home

The American College of Physicians (ACP) is offering a new, web-based tool to help guide practices through the process of becoming a patient-centered medical home (PCMH).

9 Sep 2009

Moisturizing skin helps manage Keratosis Pilaris

KP is a genetic skin condition that affects 40 percent of the world's population, often resulting in patches of dry skin, and little red bumps, on the arms and legs. KP is most prevalent in the teenage years but may continue throughout adulthood. There is no cure for Keratosis Pilaris.

9 Sep 2009

Prostate cancer treatment options discussed in a study

A new study in the Journal of the American Medical Association (JAMA) appears to support the theory outlined in earlier studies that men with more advanced forms of prostate cancer don't benefit from a combination of hormone and radiation therapy.

9 Sep 2009

Website News and Research

Results from a preclinical study of Variation's influenza vaccine to be presented at ICAAC meeting

PPJ Enterprise focuses on business development of the medical billing firm PBS

HCD Research to conduct a national study during President Barack Obama's speech on health care reform

Tetraphase to present its study on novel classes of antibiotics to treat drug-resistant infections

HHS, Ad Council and Warner Bros unite to address childhood obesity

NHSA and Together Rx Access collaborate to improve prescription access

Applications for the Pancreatic Cancer Action Network and AACR 2010 Research Grants Program invited

Season's Practice launches women health and wellness solutions in Northeast Ohio

Inspire Pharmaceuticals to increase production of azithromycin ophthalmic solution

Labopharm to present its novel trazodone formulation data

Lead exposure may result in cardiovascular mortality

New website launched on food safety

Three genes linked to Lou Gehrig's disease

Caldolor launched ahead of schedule in U.S. by Cumberland Pharmaceuticals

A voluntary recall program announced by CONMED Linvatec

Protox Therapeutics to present TRIUMPH clinical study update

Repros Therapeutics to sell 1.5 million shares to a single institutional investor

New web-based tool guide practices to become patient-centered medical home

Moisturizing skin helps manage Keratosis Pilaris

Prostate cancer treatment options discussed in a study

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News